The instant invention relates to a combination of an alpha-2-delta ligand and a PDEV inhibitor for use in therapy, particularly in the curative, prophylactic or palliative treatment of pain, particularly neuropathic pain. Particularly preferred alpha-2-delta ligands are gabapentin and pregabalin. Particularly preferred PDEV inhibitors are sildenafil, vardenafil and tadalafil.
Amino acids with affinity for the alpha-2-delta-protein
申请人:——
公开号:US20030195251A1
公开(公告)日:2003-10-16
This invention relates to certain &bgr;-amino acids that bind to the alpha-2-delta (&agr;2&dgr;) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.
Methods for using amino acids with affinity for the alpha2delta-protein
申请人:Bramson Candace
公开号:US20050124669A1
公开(公告)日:2005-06-09
This invention relates to certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.
Amino acids with affinity for the alpha2delta-protein
申请人:Barta Nancy Sue
公开号:US20050272783A1
公开(公告)日:2005-12-08
This invention relates to certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric pain and other disorders.
Methods for using amino acids with affinity for the α2δ-protein
申请人:Warner-Lambert Company LLC
公开号:US07112610B2
公开(公告)日:2006-09-26
This invention relates to certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.